Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
暂无分享,去创建一个
Robert J. Lefkowitz | J. Violin | R. Lefkowitz | E. Whalen | D. Zidar | Erin J. Whalen | Jonathan D. Violin | David A. Zidar | David A Zidar
[1] Xavier Deupi,et al. Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.
[2] T. Kohout,et al. Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7* , 2004, Journal of Biological Chemistry.
[3] R. Lefkowitz,et al. Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor* , 2004, Journal of Biological Chemistry.
[4] R. Lefkowitz,et al. Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation* , 2006, Journal of Biological Chemistry.
[5] R. Lefkowitz,et al. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] T. Kenakin. Pharmacological proteus? , 1995, Trends in pharmacological sciences.
[7] D. A. McGrath,et al. Pharmacological and signaling analysis of human chemokine receptor CCR-7 stably expressed in HEK-293 cells: high-affinity binding of recombinant ligands MIP-3beta and SLC stimulates multiple signaling cascades. , 1999, Biochemical and biophysical research communications.
[8] J. Cyster,et al. Epstein-Barr Virus–induced Molecule 1 Ligand Chemokine Is Expressed by Dendritic Cells in Lymphoid Tissues and Strongly Attracts Naive T Cells and Activated B Cells , 1998, The Journal of experimental medicine.
[9] Daniel B. McClatchy,et al. Functional specialization of β-arrestin interactions revealed by proteomic analysis , 2007, Proceedings of the National Academy of Sciences.
[10] M. Baggiolini,et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7 , 1998, European journal of immunology.
[11] R. Lefkowitz,et al. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] Robert J. Lefkowitz,et al. A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling , 2007, Proceedings of the National Academy of Sciences.
[13] N. Ling,et al. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta). , 2004, Biochemistry.
[14] S. Nickolls,et al. Identification of CC Chemokine Receptor 7 Residues Important for Receptor Activation* , 2004, Journal of Biological Chemistry.
[15] R. Lefkowitz,et al. Targeting of Diacylglycerol Degradation to M1 Muscarinic Receptors by ß-Arrestins , 2007, Science.
[16] L. Hunyady,et al. Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] Melissa A. Byers,et al. Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL211 , 2008, The Journal of Immunology.
[18] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[19] O. Yoshie,et al. Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7* , 1998, The Journal of Biological Chemistry.
[20] E. Butcher,et al. 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 , 1998, The Journal of cell biology.
[21] Robert J. Lefkowitz,et al. β-Arrestin-biased Agonism at the β2-Adrenergic Receptor* , 2008, Journal of Biological Chemistry.
[22] M. Klemsz,et al. Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. , 1997, Journal of immunology.
[23] Olivier Lichtarge,et al. β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor* , 2006, Journal of Biological Chemistry.
[24] N. Ling,et al. The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. , 2006, Biochemical and biophysical research communications.
[25] M. Groettrup,et al. Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation1 , 2006, The Journal of Immunology.
[26] R. Lefkowitz,et al. Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] Y. Yanagawa,et al. CCL19 induces rapid dendritic extension of murine dendritic cells. , 2002, Blood.
[28] M. Caron,et al. Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. , 1992, The Journal of biological chemistry.
[29] T. Kenakin. Kenakin replies: Efficacy as the molecular property of a ligand , 1995 .
[30] Robert J. Lefkowitz,et al. G-protein-coupled Receptor Kinase Specificity for β-Arrestin Recruitment to the β2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer* , 2006, Journal of Biological Chemistry.
[31] Necmettin Yildirim,et al. β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics* , 2008, Journal of Biological Chemistry.
[32] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[33] M. Caron,et al. Differential Affinities of Visual Arrestin, βArrestin1, and βArrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of Receptors* , 2000, The Journal of Biological Chemistry.
[34] M. Baggiolini,et al. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.
[35] T. Kohout,et al. Targeting of Cyclic AMP Degradation to β2-Adrenergic Receptors by β-Arrestins , 2002, Science.
[36] R. Lefkowitz,et al. Reciprocal Regulation of Angiotensin Receptor-activated Extracellular Signal-regulated Kinases by β-Arrestins 1 and 2* , 2004, Journal of Biological Chemistry.
[37] Robert J. Lefkowitz,et al. beta-arrestins: traffic cops of cell signaling. , 2004, Current opinion in cell biology.
[38] E. Wolf,et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.
[39] Xiaodong Cheng,et al. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Caron,et al. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.
[41] M. Ridanpää,et al. Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13* , 1997, The Journal of Biological Chemistry.
[42] R. Lefkowitz,et al. β-Arrestins and Cell Signaling , 2007 .